Concepts (199)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Vitrectomy | 6 | 2020 | 160 | 2.53 | Why? |
| Visual Acuity | 6 | 2020 | 790 | 2.29 | Why? |
| Cardiopulmonary Resuscitation | 13 | 2020 | 1876 | 2.04 | Why? |
| Fovea Centralis | 3 | 2020 | 26 | 1.86 | Why? |
| Basement Membrane | 3 | 2020 | 30 | 1.78 | Why? |
| Retinal Perforations | 2 | 2020 | 19 | 1.70 | Why? |
| Endotamponade | 3 | 2020 | 13 | 1.67 | Why? |
| Silicone Oils | 2 | 2018 | 7 | 1.45 | Why? |
| Retinal Detachment | 4 | 2021 | 146 | 1.11 | Why? |
| Tomography, Optical Coherence | 4 | 2020 | 1008 | 1.08 | Why? |
| Out-of-Hospital Cardiac Arrest | 5 | 2020 | 1047 | 1.02 | Why? |
| Angiogenesis Inhibitors | 3 | 2019 | 395 | 0.83 | Why? |
| Wet Macular Degeneration | 1 | 2019 | 102 | 0.70 | Why? |
| Games, Experimental | 1 | 2017 | 8 | 0.70 | Why? |
| Central Serous Chorioretinopathy | 1 | 2017 | 20 | 0.69 | Why? |
| Papilledema | 1 | 2017 | 42 | 0.66 | Why? |
| Emergency Medical Services | 4 | 2021 | 3557 | 0.65 | Why? |
| Heart Massage | 1 | 2017 | 60 | 0.64 | Why? |
| Porphyrins | 1 | 2017 | 88 | 0.64 | Why? |
| Clinical Deterioration | 1 | 2020 | 473 | 0.60 | Why? |
| Uveitis | 1 | 2018 | 233 | 0.58 | Why? |
| Pseudophakia | 1 | 2014 | 7 | 0.57 | Why? |
| Death, Sudden, Cardiac | 1 | 2020 | 522 | 0.57 | Why? |
| Coagulants | 1 | 2014 | 30 | 0.56 | Why? |
| Lenses, Intraocular | 1 | 2014 | 15 | 0.56 | Why? |
| Laser Therapy | 1 | 2017 | 158 | 0.55 | Why? |
| Phosphatidylserines | 1 | 2014 | 99 | 0.55 | Why? |
| Resuscitation | 4 | 2020 | 638 | 0.48 | Why? |
| Photochemotherapy | 1 | 2017 | 297 | 0.46 | Why? |
| Histones | 1 | 2014 | 371 | 0.45 | Why? |
| Cataract Extraction | 1 | 2014 | 201 | 0.43 | Why? |
| Arterioles | 3 | 2018 | 24 | 0.42 | Why? |
| Sports | 1 | 2017 | 690 | 0.39 | Why? |
| Schools | 5 | 2018 | 4187 | 0.38 | Why? |
| Virtual Reality | 1 | 2017 | 640 | 0.38 | Why? |
| Erythrocytes | 1 | 2014 | 617 | 0.37 | Why? |
| Diabetic Retinopathy | 3 | 2017 | 347 | 0.36 | Why? |
| Essential Hypertension | 2 | 2018 | 48 | 0.35 | Why? |
| Fundus Oculi | 2 | 2017 | 237 | 0.32 | Why? |
| Vitreous Body | 2 | 2017 | 161 | 0.31 | Why? |
| Thromboembolism | 1 | 2019 | 2101 | 0.31 | Why? |
| Heart Arrest | 5 | 2020 | 1239 | 0.30 | Why? |
| Retinal Vessels | 2 | 2018 | 255 | 0.28 | Why? |
| Fear | 1 | 2020 | 3607 | 0.28 | Why? |
| Health Promotion | 1 | 2018 | 2020 | 0.28 | Why? |
| Laser-Doppler Flowmetry | 2 | 2018 | 32 | 0.23 | Why? |
| Microscopic Angioscopy | 2 | 2018 | 58 | 0.22 | Why? |
| Blood Coagulation | 1 | 2014 | 2768 | 0.22 | Why? |
| Intravitreal Injections | 2 | 2019 | 347 | 0.20 | Why? |
| Ranibizumab | 2 | 2017 | 103 | 0.20 | Why? |
| Postoperative Complications | 1 | 2018 | 5861 | 0.19 | Why? |
| Prospective Studies | 7 | 2020 | 43301 | 0.19 | Why? |
| Retinal Artery | 1 | 2018 | 16 | 0.18 | Why? |
| Interleukin-1alpha | 1 | 2018 | 42 | 0.18 | Why? |
| Parapsychology | 1 | 2017 | 1 | 0.18 | Why? |
| Epiretinal Membrane | 1 | 2017 | 9 | 0.18 | Why? |
| Aqueous Humor | 1 | 2018 | 82 | 0.17 | Why? |
| Dihydropyridines | 1 | 2017 | 29 | 0.17 | Why? |
| Hydrochlorothiazide | 1 | 2017 | 31 | 0.17 | Why? |
| Dinoprostone | 1 | 2018 | 101 | 0.17 | Why? |
| Receptors, Formyl Peptide | 1 | 2017 | 26 | 0.17 | Why? |
| Vascular Endothelial Growth Factors | 1 | 2017 | 29 | 0.17 | Why? |
| Enalapril | 1 | 2017 | 54 | 0.17 | Why? |
| Spheroids, Cellular | 1 | 2017 | 124 | 0.17 | Why? |
| Retinal Neovascularization | 1 | 2017 | 29 | 0.17 | Why? |
| Health Knowledge, Attitudes, Practice | 1 | 2020 | 8811 | 0.16 | Why? |
| Pulse Wave Analysis | 1 | 2018 | 221 | 0.16 | Why? |
| Diagnostic Techniques, Cardiovascular | 1 | 2018 | 144 | 0.16 | Why? |
| Fluorescein Angiography | 2 | 2017 | 426 | 0.16 | Why? |
| Pilot Projects | 2 | 2020 | 5182 | 0.16 | Why? |
| Optical Imaging | 1 | 2018 | 197 | 0.16 | Why? |
| Carotid Arteries | 1 | 2018 | 182 | 0.16 | Why? |
| Choroidal Neovascularization | 1 | 2017 | 96 | 0.15 | Why? |
| Choroid | 1 | 2017 | 112 | 0.15 | Why? |
| Macular Edema | 1 | 2017 | 139 | 0.15 | Why? |
| Bevacizumab | 1 | 2017 | 149 | 0.15 | Why? |
| Xanthenes | 1 | 2014 | 3 | 0.15 | Why? |
| Fluorescein-5-isothiocyanate | 1 | 2014 | 15 | 0.15 | Why? |
| Annexin A5 | 1 | 2014 | 22 | 0.15 | Why? |
| Vascular Endothelial Growth Factor A | 1 | 2019 | 604 | 0.14 | Why? |
| Humans | 40 | 2021 | 930598 | 0.14 | Why? |
| Disease Outbreaks | 2 | 2021 | 27595 | 0.14 | Why? |
| Hypothermia, Induced | 1 | 2017 | 176 | 0.14 | Why? |
| Pharmacovigilance | 1 | 2019 | 501 | 0.14 | Why? |
| Vascular Stiffness | 1 | 2018 | 264 | 0.14 | Why? |
| Manikins | 1 | 2017 | 466 | 0.14 | Why? |
| Biological Assay | 1 | 2017 | 367 | 0.14 | Why? |
| Photosensitizing Agents | 1 | 2017 | 279 | 0.14 | Why? |
| Aniline Compounds | 1 | 2014 | 120 | 0.14 | Why? |
| Microcirculation | 1 | 2018 | 447 | 0.13 | Why? |
| Follow-Up Studies | 3 | 2018 | 17020 | 0.13 | Why? |
| Video Games | 1 | 2017 | 270 | 0.12 | Why? |
| Male | 20 | 2021 | 367725 | 0.12 | Why? |
| Infectious Disease Transmission, Professional-to-Patient | 1 | 2020 | 1316 | 0.12 | Why? |
| Female | 20 | 2021 | 380317 | 0.12 | Why? |
| Infusions, Intravenous | 1 | 2017 | 1224 | 0.12 | Why? |
| Thromboplastin | 1 | 2014 | 275 | 0.12 | Why? |
| Pandemics | 8 | 2020 | 389249 | 0.11 | Why? |
| Europe | 5 | 2021 | 12702 | 0.11 | Why? |
| Hypertension | 3 | 2018 | 8895 | 0.11 | Why? |
| Prosthesis Design | 1 | 2014 | 594 | 0.11 | Why? |
| Coronavirus | 1 | 2020 | 18339 | 0.10 | Why? |
| Italy | 5 | 2021 | 38444 | 0.10 | Why? |
| Public Opinion | 1 | 2020 | 1165 | 0.10 | Why? |
| Cattle | 1 | 2014 | 1336 | 0.10 | Why? |
| Hemodynamics | 1 | 2018 | 1562 | 0.10 | Why? |
| Students | 2 | 2018 | 5255 | 0.10 | Why? |
| Residence Characteristics | 1 | 2020 | 1927 | 0.10 | Why? |
| Calcium | 1 | 2014 | 708 | 0.10 | Why? |
| Microscopy, Video | 2 | 2018 | 63 | 0.09 | Why? |
| Survival Rate | 2 | 2020 | 9206 | 0.09 | Why? |
| Wounds and Injuries | 1 | 2020 | 1708 | 0.08 | Why? |
| Endothelial Cells | 1 | 2017 | 2048 | 0.08 | Why? |
| Pneumonia, Viral | 6 | 2020 | 243684 | 0.08 | Why? |
| Aged | 10 | 2021 | 215776 | 0.08 | Why? |
| Blood Pressure | 4 | 2018 | 2198 | 0.08 | Why? |
| Coronavirus Infections | 6 | 2020 | 253789 | 0.08 | Why? |
| Smartphone | 1 | 2017 | 1840 | 0.08 | Why? |
| Oxidative Stress | 1 | 2017 | 2050 | 0.07 | Why? |
| Flow Cytometry | 1 | 2014 | 2393 | 0.07 | Why? |
| Health Education | 1 | 2017 | 1539 | 0.07 | Why? |
| Human Umbilical Vein Endothelial Cells | 2 | 2017 | 286 | 0.07 | Why? |
| Betacoronavirus | 6 | 2020 | 204454 | 0.07 | Why? |
| Pediatrics | 1 | 2020 | 2969 | 0.07 | Why? |
| Child | 6 | 2020 | 70012 | 0.07 | Why? |
| Recombinant Proteins | 1 | 2014 | 3786 | 0.07 | Why? |
| Neovascularization, Pathologic | 2 | 2017 | 305 | 0.06 | Why? |
| Drug Therapy, Combination | 1 | 2017 | 7268 | 0.06 | Why? |
| Phenotype | 1 | 2014 | 4037 | 0.06 | Why? |
| Blood Platelets | 1 | 2014 | 1704 | 0.06 | Why? |
| Inflammation | 2 | 2017 | 13255 | 0.06 | Why? |
| Chronic Disease | 1 | 2017 | 5139 | 0.06 | Why? |
| Age Factors | 3 | 2017 | 21039 | 0.06 | Why? |
| Treatment Outcome | 2 | 2020 | 51732 | 0.06 | Why? |
| CD4-Positive T-Lymphocytes | 1 | 2017 | 4545 | 0.06 | Why? |
| Longitudinal Studies | 1 | 2017 | 9893 | 0.06 | Why? |
| Surveys and Questionnaires | 2 | 2018 | 43792 | 0.05 | Why? |
| Myography | 1 | 2018 | 6 | 0.05 | Why? |
| Hospital Restructuring | 1 | 2021 | 188 | 0.05 | Why? |
| Diabetes Mellitus | 1 | 2021 | 8207 | 0.05 | Why? |
| Emergency Service, Hospital | 2 | 2021 | 14232 | 0.05 | Why? |
| Incidence | 1 | 2020 | 25622 | 0.05 | Why? |
| American Heart Association | 1 | 2020 | 347 | 0.04 | Why? |
| Thinness | 1 | 2018 | 99 | 0.04 | Why? |
| Air Ambulances | 1 | 2021 | 202 | 0.04 | Why? |
| Vascular Remodeling | 1 | 2018 | 99 | 0.04 | Why? |
| Gels | 1 | 2017 | 111 | 0.04 | Why? |
| Middle Aged | 9 | 2021 | 270681 | 0.04 | Why? |
| Ophthalmoscopy | 1 | 2017 | 65 | 0.04 | Why? |
| Subcutaneous Fat | 1 | 2018 | 94 | 0.04 | Why? |
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 9706 | 0.04 | Why? |
| Vascular Resistance | 1 | 2018 | 148 | 0.04 | Why? |
| Reproducibility of Results | 3 | 2018 | 11304 | 0.04 | Why? |
| Fibrin | 1 | 2017 | 145 | 0.04 | Why? |
| Retrospective Studies | 4 | 2021 | 105322 | 0.04 | Why? |
| Arteries | 1 | 2018 | 283 | 0.04 | Why? |
| Audiovisual Aids | 1 | 2017 | 138 | 0.04 | Why? |
| Hospitals, Urban | 1 | 2021 | 950 | 0.04 | Why? |
| Photography | 1 | 2017 | 255 | 0.04 | Why? |
| Biomarkers | 1 | 2018 | 23361 | 0.03 | Why? |
| Child, Preschool | 1 | 2018 | 36283 | 0.03 | Why? |
| Anesthesiologists | 1 | 2020 | 614 | 0.03 | Why? |
| Calcium Channel Blockers | 1 | 2017 | 367 | 0.03 | Why? |
| Analysis of Variance | 1 | 2017 | 950 | 0.03 | Why? |
| Asia | 1 | 2021 | 2399 | 0.03 | Why? |
| Time Factors | 1 | 2017 | 31397 | 0.03 | Why? |
| China | 1 | 2020 | 50654 | 0.03 | Why? |
| Hospitals, Community | 1 | 2017 | 475 | 0.03 | Why? |
| Predictive Value of Tests | 2 | 2018 | 9537 | 0.03 | Why? |
| Animals | 3 | 2018 | 78931 | 0.03 | Why? |
| Personal Protective Equipment | 3 | 2021 | 15978 | 0.03 | Why? |
| Infection Control | 1 | 2020 | 23131 | 0.03 | Why? |
| Operating Rooms | 1 | 2021 | 1841 | 0.02 | Why? |
| Adolescent | 2 | 2017 | 86841 | 0.02 | Why? |
| Biopsy | 1 | 2018 | 2811 | 0.02 | Why? |
| Adult | 4 | 2020 | 244371 | 0.02 | Why? |
| Health Care Surveys | 1 | 2017 | 2942 | 0.02 | Why? |
| Multivariate Analysis | 1 | 2018 | 5440 | 0.02 | Why? |
| Critical Care | 2 | 2021 | 14081 | 0.02 | Why? |
| Quality of Health Care | 1 | 2017 | 1948 | 0.02 | Why? |
| Antihypertensive Agents | 1 | 2017 | 1962 | 0.02 | Why? |
| Internationality | 1 | 2017 | 3297 | 0.02 | Why? |
| Evidence-Based Medicine | 1 | 2017 | 3228 | 0.02 | Why? |
| Hospitals, University | 1 | 2017 | 4173 | 0.02 | Why? |
| Societies, Medical | 1 | 2020 | 6907 | 0.02 | Why? |
| United States | 2 | 2021 | 46150 | 0.02 | Why? |
| Intensive Care Units | 2 | 2021 | 29594 | 0.01 | Why? |
| Germany | 1 | 2017 | 9196 | 0.01 | Why? |
| Cell Line | 1 | 2017 | 12040 | 0.01 | Why? |
| Communicable Disease Control | 2 | 2021 | 29620 | 0.01 | Why? |
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2017 | 5277 | 0.01 | Why? |
| Infant, Newborn | 1 | 2020 | 23105 | 0.01 | Why? |
| Obesity | 1 | 2018 | 7388 | 0.01 | Why? |
| Mice | 1 | 2017 | 21357 | 0.01 | Why? |
| Comorbidity | 1 | 2021 | 34796 | 0.01 | Why? |
| Risk Assessment | 1 | 2020 | 25439 | 0.01 | Why? |
| Prognosis | 1 | 2018 | 32490 | 0.01 | Why? |
| Risk Factors | 1 | 2021 | 71621 | 0.01 | Why? |
| Aged, 80 and over | 1 | 2017 | 88759 | 0.00 | Why? |
Semeraro's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(199)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(71)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_